Trending

Lagos University Teaching Hospital, LUTH have confirmed two patients, whose cases were presented late has died from Lassa fever. The Chief Medical Director, Chris Bode, while confirming the incident said no less than 100 hospital workers from different hospitals who had been exposed to the patients are also under close monitoring. One of the dead victims, a 32 years old pregnant woman with bleeding disorder, died after a still birth and already had a post-mortem examination conducted on her before her Lassa status was confirmed.

Researchers in the US have claimed that loneliness is deadlier than obesity and should be considered a major public health hazard. The researchers looked at 218 studies into the health effects of social isolation and loneliness involving nearly four million people.

A recent study suggests that people who eat a lot of saturated fat - the “bad” kind of fat that’s abundant in foods like butter and beef - are more likely to develop lung cancer than individuals on low-fat diets.

A research by a group of American scientists showed that cows have an insane and mind-blowing ability to tackle HIV which will assist in developing vaccine, the study said. A new study supported by the National Institutes of Health made a big step towards developing what could be a viable HIV vaccine, after an experiment with cows, the BBC News reports.

Kitchen sponges are dirtier than toilets teeming with bacteria, researchers found. A group of researchers from the Faculty of Medical and Life Sciences, Institute of Precision Medicine (IPM), Microbiology and Hygiene Group, Furtwangen University in Germany conducted DNA analysis of 14 different kitchen sponges. The researchers said their study revealed "an amazing bacterial colonization of kitchen sponges, and visualized its extent for this common microbial hot spot for the first time."

Drugs that can protect people from HIV infection will be available to those at risk from September, NHS England has said. PrEP (pre-exposure prophylaxis) in the form of a once-a-day pill called Truvada will be available to at least 10,000 people whose partners may be HIV-positive through sexual health clinics, which can put them forward for inclusion in a large clinical trial.